Novinky
Introduction of MLPA method
We have introduced the examination of selected genes using MLPA method (Multiplex Ligation-dependent Probe Amplification = “multiplication of many ligated probes”). This method reveals large gene rearrangements by measuring the number of copies of individual gene segments. In this manner it is possible to identify such mutations, which can not be found in another way.
Examination of the BRCA1 and BRCA2 genes
Newly we provide molecular genetic testing of the BRCA1 and BRCA2 genes. Changes (mutations) in these genes are the most significant genetic cause of increased risk of breast and ovarian cancer, and to a lesser extent also of cancer of other organs.
Change of the logo and the graphics
Company GENvia,s.r.o. changes and unifies the existing graphical form of used documents, including the company logo. Step by step they will be updated and replaced all the valid forms.
Calendars 2015
Validity of the work permit of the diagnostic laboratory
Based on the result of the inspectional audit, SÚKL prolonged the Work permit of the diagnostic laboratory GENvia.
Change of the e-mail contacts
Because of the full transition to the domain genvia.cz were the e-mail addresses changed as follows:
Genetic clinic:
ambulance@genvia.cz
Genetic laboratory:
laborator@genvia.cz
Company management:
info@genvia.cz
Financial accounting department:
faktury@genvia.cz
The original addresses (ambulance.genvia@volny.cz and laborator.genvia@volny.cz) remain further active and will be redirected to the new mailboxes.
New ambulance in Hloubetín
We opened for our clients a new genetic clinic in Hloubetín. Contact information can be found in the section Contacts.